Clinical Study

The Impact of Hyperglycemic Emergencies on the Kidney and Liver

Table 3

Basal clinical and biochemical characteristics of the DK and DKA patients with and without infection.

VariablesNoninfection DK
( )
Infection DK
( )
valueNoninfection DKA
( )
Infection DKA
( )
value

Female/male ( )6/208/60.0318/1314/50.020
Age (years) 0.050 0.022
Duration of diabetes (years)0.00 (0.00–8.00)1.00 (0.00–12.00)0.2944.00 (0.00–26.00)7.00 (0.00–18.00)0.141
Plasma glucose (mmol/L) 0.136 0.010
HbA1c (%) 0.943 0.659
Arterial pH 0.142 0.747
HCO3 (mmol/L) 0.491 0.279
Alanine aminotransferase (U/L) 0.001 0.673
Aspartate aminotransferase (U/L) 0.382 0.604
-glutamyl transpeptidase (U/L) 0.948 0.306
Total bilirubin (μmol/L) 0.175 0.806
Direct bilirubin (μmol/L) 0.394 0.500
Total protein (g/L) 0.220 0.547
Albumin (g/L) 0.016 0.062
Globulin (g/L) 0.208 0.806
Prealbumin (mg/dL) 0.707 0.645
Serum creatinine (μmol/L) 0.677 0.926
eGFR (mL/min per 1.73 m2) 0.136 0.413
Uric acid (μmol/L) 0.883 0.572

All values in the table are given as the mean ± standard deviation, except for the duration of diabetes, which is given as the median and range (min–max).